• Lutte contre les cancers

  • Analyses économiques et systèmes de soins

Analysis of Price Transparency for Oncologic Surgery Among National Cancer Institute–Designated Cancer Centers in 2020

Menée aux Etats-Unis dans les centres de lutte contre le cancer, cette étude analyse l'information disponible pour les patients atteints d'un cancer concernant les prix des soins, et notamment le prix des actes chirurgicaux

In January 2019, the Centers for Medicare and Medicaid Services (CMS) began legally requiring hospitals to publish chargemasters online to promote price transparency. Hospital chargemasters list gross charges for all items and services, which are the undiscounted prices hospitals bill patients who are uninsured, self pay, or have out-of-network insurance. Understanding the cost of care is important for patients with cancer, who often suffer considerable financial burdens. However, a recent analysis examining price transparency for radiation therapy has raised concerns about the utility of public chargemasters. We therefore sought to investigate the information available to patients with cancer seeking surgical care at National Cancer Institute (NCI)–designated cancer centers.

JAMA Surgery 2021

View the bulletin